What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read Pharma Industry News Alamar Biosciences and DZNE partner to profile 23,000 samples in landmark neurodegeneration biomarker study Alamar Biosciences partners with DZNE to deploy its NULISAseq panels in the Rhineland Study, profiling 23,000 plasma samples for aging and dementia biomarker discovery. bySoujanya RaviJuly 29, 2025